MAPT and Alzheimer disease: Looking into the cellular level changes in an AD brain, various molecular pathways and intracellular signaling are dysregulated, which include Aβ and tau, inflammatory-immune responses, homeostasis and plasticity of synapses, and oxidative stress and their dysregulation results from genetic, environmental, and biologic interventions [17,18].